Anticancer Bioscience

Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies.

[Anticancer Bioscience @anticancerbio]

We are excited to collaborate with @DelSiTech, a leading silica drug delivery technology company, for the development of controlled-release cancer therapies. Learn more about the collaboration at: https://t.co/8EoG7q78hO

[Anticancer Bioscience @anticancerbio]

Congratulations to our Founder, President and CEO, Dun Yang, Ph.D. who has been named an In Vivo Rising Leader 2022. @INVIVOnow's 30 Rising Leaders recognize entrepreneurs and innovators who represent the next wave of creativity in health care.
Read more:https://t.co/moT9fKxuwS

[Anticancer Bioscience @anticancerbio]

On #WorldCancerDay, Our VP @JingZhang_ACB was interviewed by @LSXLeaders #FemaleFounders where she discussed the inspiration that let her focus on #cancer and improvements in care/treatments for patients she hopes to see in future.
Read the full interview: https://t.co/HdgeZRNG77

[Anticancer Bioscience @anticancerbio]

On this #WorldCancerDay and every other day of the year, Anticancer Bioscience is committed to discovering and developing safer and better #cancer therapies that dramatically extend and improve patients’ lives.

[Anticancer Bioscience @anticancerbio]

Anticancer Bioscience wishes you a healthy, happy and bright holiday season, and a wonderful new year.

#HappyHolidays #MerryChritsmas #HappyNewYear

[Anticancer Bioscience @anticancerbio]

Many thanks to @DDWJournal for the great article featuring our move to the new headquarters.

For more information about our #SyntheticLethal drug discovery pipeline, technology platforms, partnering and vacancies, follow us and visit https://t.co/Ch9xBzzago.

[Drug Discovery World @DDWJournal]

Anticancer Bioscience expands to Chinese biotech research park

https://t.co/B2JkftnpsK

@anticancerbio #Biotechnology

[Anticancer Bioscience @anticancerbio]

Today we are proud to announce we have relocated to Tianfu International Biotown, the premier #biotech research park in #Chengdu, #China. The move accommodates our #growth and #expansion, on the back of our recent #financing.
Read more at: https://t.co/8LzA6KdoZ5
#drugdiscovery

[Anticancer Bioscience @anticancerbio]

Happy #Thanksgiving from all of us at Anticancer Bioscience! We are grateful for our teams, investors, partners, collaborators and friends who support us on our journey to transform breakthrough #science into effective #medicine.
#Thanksgiving2021

[Anticancer Bioscience @anticancerbio]

We will be attending the Inv€$tival Showcase hosted by @LSX next week. We look forward to connecting with our future partners.

To learn more about our discovery platforms and impressive pipeline visit https://t.co/Xs4DlZoXjl.
#Investival #oncology #precisionmedicine #biotech

[Anticancer Bioscience @anticancerbio]

Thank you for selecting us and for a well-written summary highlighting ‘our expertise in #synthetic_lethal approaches to precision oncology, #MYC biology, and cell division which has allowed us to build a broad pipeline that paves the way to develop novel cancer therapies.’

[The Silicon Review @Dsiliconreview]

@Anticancer_Bioscience (ACB) is a precision therapeutics company specializing in synthetic lethal approaches to develop targeted cancer therapies, has been named one among #The_Silicon_Review "50 Most Admired Companies of the Year 2021" @anticancerbio
https://t.co/FnJPxBFfbp

[Anticancer Bioscience @anticancerbio]

Happy #Diwali to our colleagues in #India and to our followers who celebrate this festival. May this Festival of Lights bring joy and good health to you all.

#Diwali2021 #FestivalOfLights #FestivalOfLights2021

[Anticancer Bioscience @anticancerbio]

Great review of the evolution of Chinese #biotech by @AmberTongPW.
Thank you to all entrepreneurs that have gone before us to create the exciting Biopharma industry in #China. We are pleased to be part of the next wave ‘innovating for the world’.
#oncology #myc #drugdiscovery

[Endpoints News @endpts]

While setting up a company in China for China was once a bold and revolutionary concept, many around the country's biotech ecosystem now have a new mantra: "in China, for the world." Read more about the shifts happening here in our latest feature.

https://t.co/tEr5As6nQg

[Anticancer Bioscience @anticancerbio]

Thanks @AmberTongPW for covering us in the News Briefing.

[Endpoints News @endpts]

In today's News Briefing: Exelixis and RNA-focused biotech Storm Therapeutics entered into an exclusive collaboration and license agreement, the companies jointly announced today.

https://t.co/m6NgeWMtri

[Anticancer Bioscience @anticancerbio]

We are delighted to announce that we have raised an additional ¥68.4m (~$10.6m), bringing the total equity raised to ¥200m (~$31m). We will use this #financing to advance our #MYC-#syntheticlethal and contact inhibition restoration programs. Read more here:https://t.co/DeboldAuTk

[Anticancer Bioscience @anticancerbio]

Check out our new beautiful website at https://t.co/Xs4DlZoXjl!
The new site provides deeper background on our vision and heritage, and full details on our discovery platforms, unique natural products and chemical libraries, and 5 discovery programs based on #syntheticlethality.

[Anticancer Bioscience @anticancerbio]

An interesting review on MYC from our advisor @LabDfelsher.

MYC is activated in many cancers but no direct inhibitors of MYC are approved yet.

We are taking the #SyntheticLethal approach to target #MYC-overexpressing cells and are advancing the MYC-SL program to the clinic.

[soria @jsoriamd]

The MYC oncogene : the grand orchestrator of cancer growth & immune evasion and a long lasting rebellious target
https://t.co/wDHlWhTcNj

[Anticancer Bioscience @anticancerbio]

We are delighted to announce our first granted US patent, entitled “cancer treatment using compounds that selectively target polyploid cancer cells for disruption”, which was issued by the USPTO on Aug 31.

Read the full release: https://t.co/rq01wqeW8t

#syntheticlethal #MYC

[Anticancer Bioscience @anticancerbio]

“ACB is using deep knowledge of cell and cancer biology to develop next-generation targeted oncology therapies. The goal is to deliver first-in-class oncology drugs against unexplored targets.”

Read the full article on https://t.co/MdhqLsrYtC: https://t.co/S6Fs8SW6B6

[Anticancer Bioscience @anticancerbio]

Check out our latest publication in the Journal of Natural Products: https://t.co/ZYRSjs0OZW Another example demonstrating the lead compound discovery power of our proprietary #NaturalProducts library platform and unique mechanism-informed, image-based #HTS screening approach.

[Anticancer Bioscience @anticancerbio]

An experienced R&D leader, Dr. Hong Liu, joined us as VP of Clinical Development as we continue our international expansion.
Follow us or visit https://t.co/InC4TFtssa to learn more about our team and pipeline of #MYC-#SyntheticLethal drugs. https://t.co/zH6FL2hiPw
#oncology